Zuzana Tothova, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Chromosomal Proteins, Non-Histone | 5 | 2024 | 724 | 1.830 |
Why?
|
Myelodysplastic Syndromes | 4 | 2024 | 1399 | 1.460 |
Why?
|
Cell Cycle Proteins | 7 | 2024 | 3450 | 1.230 |
Why?
|
Myeloproliferative Disorders | 5 | 2021 | 616 | 1.110 |
Why?
|
Leukemia, Myeloid, Acute | 5 | 2024 | 3626 | 0.930 |
Why?
|
Leukemia, Myeloid | 2 | 2021 | 693 | 0.680 |
Why?
|
Mutation | 9 | 2024 | 30266 | 0.650 |
Why?
|
Hematopoietic Stem Cells | 8 | 2021 | 3408 | 0.650 |
Why?
|
Forkhead Transcription Factors | 7 | 2011 | 1625 | 0.620 |
Why?
|
DNA Repair | 3 | 2024 | 2054 | 0.500 |
Why?
|
Hematopoiesis | 3 | 2017 | 2059 | 0.460 |
Why?
|
Granuloma, Plasma Cell | 1 | 2012 | 80 | 0.380 |
Why?
|
Lymphohistiocytosis, Hemophagocytic | 1 | 2014 | 271 | 0.340 |
Why?
|
Neoplastic Stem Cells | 4 | 2016 | 1356 | 0.330 |
Why?
|
Hematologic Neoplasms | 1 | 2021 | 1907 | 0.330 |
Why?
|
RNA Splicing | 2 | 2024 | 905 | 0.330 |
Why?
|
Neoplasm Proteins | 1 | 2021 | 3608 | 0.320 |
Why?
|
Hematopoietic System | 1 | 2007 | 110 | 0.280 |
Why?
|
Radiation Tolerance | 1 | 2009 | 478 | 0.270 |
Why?
|
Phosphoproteins | 2 | 2024 | 2452 | 0.240 |
Why?
|
Blood Cells | 1 | 2007 | 309 | 0.240 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2012 | 1629 | 0.240 |
Why?
|
DNA Damage | 3 | 2024 | 2472 | 0.230 |
Why?
|
Genome, Human | 1 | 2017 | 4456 | 0.230 |
Why?
|
Chondroitin Sulfate Proteoglycans | 1 | 2024 | 142 | 0.230 |
Why?
|
Reactive Oxygen Species | 2 | 2009 | 2149 | 0.220 |
Why?
|
Cell Lineage | 4 | 2017 | 2576 | 0.200 |
Why?
|
Stress, Mechanical | 1 | 2007 | 1680 | 0.190 |
Why?
|
Leukemia | 3 | 2017 | 1520 | 0.190 |
Why?
|
Nuclear Matrix-Associated Proteins | 1 | 2021 | 38 | 0.190 |
Why?
|
Chromatin | 3 | 2021 | 2981 | 0.190 |
Why?
|
Leukemia, Erythroblastic, Acute | 1 | 2021 | 176 | 0.190 |
Why?
|
Protein Kinase Inhibitors | 2 | 2017 | 5707 | 0.190 |
Why?
|
Models, Biological | 1 | 2017 | 9499 | 0.180 |
Why?
|
Critical Care | 1 | 2014 | 2716 | 0.180 |
Why?
|
U937 Cells | 1 | 2021 | 260 | 0.180 |
Why?
|
Epigenesis, Genetic | 3 | 2021 | 3836 | 0.180 |
Why?
|
Wills | 1 | 2019 | 13 | 0.160 |
Why?
|
K562 Cells | 1 | 2021 | 648 | 0.160 |
Why?
|
Cell Differentiation | 7 | 2021 | 11684 | 0.160 |
Why?
|
Phthalazines | 1 | 2021 | 397 | 0.150 |
Why?
|
Nuclear Proteins | 2 | 2024 | 5804 | 0.150 |
Why?
|
Gene Expression Regulation, Leukemic | 1 | 2021 | 658 | 0.150 |
Why?
|
Mice, Mutant Strains | 1 | 2021 | 1755 | 0.150 |
Why?
|
Antigens, CD34 | 2 | 2017 | 656 | 0.140 |
Why?
|
Zygote | 1 | 2017 | 117 | 0.140 |
Why?
|
Mice, Inbred NOD | 1 | 2021 | 1839 | 0.130 |
Why?
|
Mice | 17 | 2021 | 82072 | 0.130 |
Why?
|
Histone Demethylases | 1 | 2019 | 328 | 0.130 |
Why?
|
Mice, Transgenic | 5 | 2021 | 9565 | 0.130 |
Why?
|
CLOCK Proteins | 1 | 2016 | 87 | 0.130 |
Why?
|
Mice, SCID | 1 | 2021 | 2631 | 0.130 |
Why?
|
ARNTL Transcription Factors | 1 | 2016 | 97 | 0.130 |
Why?
|
Oxidative Stress | 1 | 2007 | 3139 | 0.130 |
Why?
|
Gene Expression Regulation, Neoplastic | 4 | 2022 | 8664 | 0.120 |
Why?
|
Calreticulin | 1 | 2016 | 115 | 0.120 |
Why?
|
Receptors, Thrombopoietin | 1 | 2016 | 159 | 0.120 |
Why?
|
Genes, ras | 1 | 2017 | 665 | 0.110 |
Why?
|
Clone Cells | 1 | 2017 | 1670 | 0.110 |
Why?
|
Protein Interaction Domains and Motifs | 1 | 2016 | 450 | 0.110 |
Why?
|
RNA-Binding Proteins | 1 | 2021 | 1891 | 0.100 |
Why?
|
Animals | 18 | 2021 | 169335 | 0.100 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2021 | 3621 | 0.100 |
Why?
|
Cell Transformation, Neoplastic | 2 | 2016 | 2848 | 0.100 |
Why?
|
ras Proteins | 1 | 2017 | 1058 | 0.100 |
Why?
|
Oncogene Protein v-akt | 1 | 2011 | 130 | 0.090 |
Why?
|
Transcription Factors | 4 | 2024 | 12174 | 0.090 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2013 | 719 | 0.090 |
Why?
|
Gene Targeting | 1 | 2014 | 841 | 0.090 |
Why?
|
DNA-Binding Proteins | 3 | 2024 | 9618 | 0.090 |
Why?
|
Cell Line, Tumor | 5 | 2021 | 17173 | 0.090 |
Why?
|
Genetic Engineering | 1 | 2016 | 936 | 0.090 |
Why?
|
Humans | 21 | 2024 | 768970 | 0.080 |
Why?
|
Gene Fusion | 1 | 2012 | 357 | 0.080 |
Why?
|
Mice, Inbred C57BL | 6 | 2021 | 22379 | 0.080 |
Why?
|
Disease Models, Animal | 5 | 2021 | 18354 | 0.080 |
Why?
|
Prognosis | 2 | 2024 | 30046 | 0.080 |
Why?
|
Neoplasms | 3 | 2024 | 22389 | 0.080 |
Why?
|
STAT Transcription Factors | 2 | 2022 | 189 | 0.080 |
Why?
|
Radiation, Ionizing | 1 | 2009 | 252 | 0.070 |
Why?
|
PTEN Phosphohydrolase | 2 | 2011 | 1120 | 0.070 |
Why?
|
Janus Kinases | 2 | 2022 | 253 | 0.070 |
Why?
|
Gene Silencing | 1 | 2014 | 1505 | 0.070 |
Why?
|
Hematopoietic Stem Cell Transplantation | 2 | 2017 | 5716 | 0.070 |
Why?
|
Lymphoma, T-Cell | 2 | 2007 | 308 | 0.070 |
Why?
|
Retinol-Binding Proteins | 1 | 2007 | 67 | 0.070 |
Why?
|
Salvage Therapy | 1 | 2014 | 1277 | 0.070 |
Why?
|
Megakaryocytes | 1 | 2011 | 571 | 0.070 |
Why?
|
Leukemia, Myelomonocytic, Chronic | 1 | 2007 | 93 | 0.070 |
Why?
|
Receptors, Notch | 1 | 2011 | 751 | 0.070 |
Why?
|
Chromosome Aberrations | 1 | 2013 | 1780 | 0.070 |
Why?
|
Genes, Tumor Suppressor | 1 | 2010 | 1064 | 0.070 |
Why?
|
Multipotent Stem Cells | 1 | 2007 | 201 | 0.060 |
Why?
|
Proto-Oncogene Proteins c-akt | 2 | 2011 | 2460 | 0.060 |
Why?
|
Genotype | 2 | 2017 | 13048 | 0.060 |
Why?
|
RNA | 1 | 2014 | 2727 | 0.060 |
Why?
|
Spliceosomes | 1 | 2024 | 116 | 0.060 |
Why?
|
fms-Like Tyrosine Kinase 3 | 1 | 2007 | 494 | 0.060 |
Why?
|
Gene Deletion | 1 | 2010 | 2674 | 0.050 |
Why?
|
Cell Proliferation | 2 | 2009 | 10486 | 0.050 |
Why?
|
Myeloid Cells | 1 | 2007 | 840 | 0.050 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2010 | 2063 | 0.050 |
Why?
|
Breast Neoplasms | 1 | 2009 | 21188 | 0.050 |
Why?
|
Mice, Knockout | 3 | 2021 | 14484 | 0.050 |
Why?
|
Immunosuppressive Agents | 1 | 2014 | 4207 | 0.050 |
Why?
|
Antineoplastic Agents | 2 | 2014 | 13698 | 0.040 |
Why?
|
Intensive Care Units | 1 | 2014 | 3800 | 0.040 |
Why?
|
Cell Survival | 2 | 2007 | 5793 | 0.040 |
Why?
|
Telomerase | 1 | 2005 | 753 | 0.040 |
Why?
|
Erythroid Cells | 1 | 2021 | 238 | 0.040 |
Why?
|
Genomics | 1 | 2016 | 5928 | 0.040 |
Why?
|
Homeostasis | 2 | 2007 | 3347 | 0.040 |
Why?
|
Aged, 80 and over | 1 | 2024 | 59739 | 0.040 |
Why?
|
Signal Transduction | 6 | 2016 | 23653 | 0.040 |
Why?
|
Antioxidants | 1 | 2007 | 1673 | 0.040 |
Why?
|
Lymphocytes | 1 | 2007 | 2614 | 0.040 |
Why?
|
Gene Expression Regulation | 2 | 2007 | 11932 | 0.040 |
Why?
|
Cell Cycle | 1 | 2007 | 2937 | 0.040 |
Why?
|
Diagnosis, Differential | 1 | 2014 | 13021 | 0.040 |
Why?
|
Cell Line | 3 | 2022 | 15604 | 0.040 |
Why?
|
Genetic Predisposition to Disease | 1 | 2019 | 18068 | 0.030 |
Why?
|
Tumor Suppressor Proteins | 1 | 2007 | 2812 | 0.030 |
Why?
|
Structure Collapse | 1 | 2016 | 4 | 0.030 |
Why?
|
Bone Marrow | 1 | 2007 | 2936 | 0.030 |
Why?
|
Histones | 1 | 2007 | 2603 | 0.030 |
Why?
|
Female | 4 | 2024 | 397515 | 0.030 |
Why?
|
Apoptosis | 2 | 2011 | 9527 | 0.030 |
Why?
|
Male | 3 | 2024 | 365203 | 0.030 |
Why?
|
Kinetics | 1 | 2022 | 6332 | 0.030 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2004 | 2433 | 0.030 |
Why?
|
Cells, Cultured | 4 | 2011 | 19023 | 0.030 |
Why?
|
Embryonic Stem Cells | 1 | 2021 | 1251 | 0.030 |
Why?
|
Frameshift Mutation | 1 | 2016 | 393 | 0.030 |
Why?
|
Endothelial Cells | 1 | 2007 | 3592 | 0.030 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2004 | 1437 | 0.030 |
Why?
|
Lovastatin | 1 | 2013 | 115 | 0.030 |
Why?
|
NF-kappa B | 1 | 2022 | 2492 | 0.030 |
Why?
|
Gene Library | 1 | 2016 | 1062 | 0.030 |
Why?
|
Transcription, Genetic | 1 | 2007 | 7609 | 0.030 |
Why?
|
Gene Knockout Techniques | 1 | 2016 | 808 | 0.030 |
Why?
|
Up-Regulation | 1 | 2022 | 4148 | 0.030 |
Why?
|
Cell Nucleus | 1 | 2021 | 2885 | 0.030 |
Why?
|
Flow Cytometry | 2 | 2014 | 5906 | 0.020 |
Why?
|
Streptococcus pyogenes | 1 | 2014 | 293 | 0.020 |
Why?
|
Aged | 1 | 2024 | 171786 | 0.020 |
Why?
|
Receptor Cross-Talk | 1 | 2011 | 118 | 0.020 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2009 | 9442 | 0.020 |
Why?
|
Drug Resistance | 1 | 2016 | 1599 | 0.020 |
Why?
|
Middle Aged | 1 | 2024 | 223737 | 0.020 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 1 | 2011 | 440 | 0.020 |
Why?
|
Adult | 1 | 2024 | 223851 | 0.020 |
Why?
|
RNA, Messenger | 1 | 2024 | 12806 | 0.020 |
Why?
|
Thrombopoiesis | 1 | 2011 | 166 | 0.020 |
Why?
|
Bone Marrow Transplantation | 1 | 2016 | 2709 | 0.020 |
Why?
|
Genome | 1 | 2016 | 1754 | 0.020 |
Why?
|
Retinol-Binding Proteins, Cellular | 1 | 2007 | 12 | 0.020 |
Why?
|
RNA Interference | 1 | 2016 | 2835 | 0.020 |
Why?
|
Leukemia, Experimental | 1 | 2007 | 225 | 0.020 |
Why?
|
Spodoptera | 1 | 2007 | 140 | 0.020 |
Why?
|
RNA, Small Interfering | 1 | 2016 | 3433 | 0.020 |
Why?
|
Treatment Outcome | 1 | 2013 | 65480 | 0.020 |
Why?
|
Fibroblasts | 2 | 2007 | 4179 | 0.020 |
Why?
|
NIH 3T3 Cells | 1 | 2007 | 669 | 0.020 |
Why?
|
Base Sequence | 1 | 2016 | 12430 | 0.010 |
Why?
|
Circadian Rhythm | 1 | 2016 | 2593 | 0.010 |
Why?
|
Mice, Inbred Strains | 1 | 2007 | 1769 | 0.010 |
Why?
|
Phenotype | 2 | 2016 | 16731 | 0.010 |
Why?
|
Methylation | 1 | 2007 | 1078 | 0.010 |
Why?
|
Bone Marrow Cells | 1 | 2011 | 2414 | 0.010 |
Why?
|
Protein Binding | 1 | 2016 | 9344 | 0.010 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2007 | 1683 | 0.010 |
Why?
|
Embryo, Nonmammalian | 1 | 2007 | 910 | 0.010 |
Why?
|
Solubility | 1 | 2005 | 1087 | 0.010 |
Why?
|
Down-Regulation | 1 | 2010 | 2942 | 0.010 |
Why?
|
Hemangioma | 1 | 2007 | 727 | 0.010 |
Why?
|
Exons | 1 | 2007 | 2395 | 0.010 |
Why?
|
Embryo, Mammalian | 1 | 2007 | 1676 | 0.010 |
Why?
|
Protein Structure, Tertiary | 1 | 2007 | 3775 | 0.010 |
Why?
|
Neovascularization, Physiologic | 1 | 2007 | 1371 | 0.010 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2005 | 2525 | 0.010 |
Why?
|
Telomere | 1 | 2005 | 943 | 0.010 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2013 | 3253 | 0.010 |
Why?
|
Mice, Inbred BALB C | 1 | 2007 | 6232 | 0.010 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2007 | 3810 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2005 | 4592 | 0.010 |
Why?
|
Lymphoma | 1 | 2007 | 1900 | 0.010 |
Why?
|
Drosophila Proteins | 1 | 2007 | 1712 | 0.010 |
Why?
|
Homeodomain Proteins | 1 | 2007 | 2431 | 0.010 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2007 | 2884 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2007 | 6547 | 0.010 |
Why?
|
Cell Division | 1 | 2004 | 4478 | 0.010 |
Why?
|
Nerve Tissue Proteins | 1 | 2007 | 4413 | 0.010 |
Why?
|
Cytokines | 1 | 2007 | 7453 | 0.010 |
Why?
|
Survival Rate | 1 | 2004 | 12873 | 0.010 |
Why?
|